In a controversial foreign trip, President Trump secures a staggering $600 billion investment deal with Saudi Arabia, raising eyebrows about his business ties and ethical standards.
As cardinals gather to discuss the future of the Catholic Church after Pope Francis' death, deep divisions emerge over ecclesiastical power and potential successors. Can Pietro Parolin unite the factions or will he ignite further controversy?
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
After decades of lobbying, the US government is finally warning consumers about the dangers of ultra-processed foods. With new nutrition labels proposed, experts weigh in on their potential effectiveness and what more needs to be done to improve public health.
